Oral Contraceptive Use and IGF-1 Levels in Women
Author Information
Author(s): Kristina M Blackmore, Jody Wong, Julia A Knight
Primary Institution: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
Hypothesis
What is the relationship between different patterns of oral contraceptive use and circulating IGF-1 levels among premenopausal women?
Conclusion
The study shows that past use of oral contraceptives can have long-term effects on IGF-1 levels in premenopausal women.
Supporting Evidence
- Women aged 18 to 21 who ever used oral contraceptives had significantly lower IGF-1 levels compared to never users.
- Among women aged 31 to 40, past users who first used oral contraceptives at 25 years or older had significantly higher IGF-1 levels compared to never users.
- The study highlights the importance of considering the timing and type of oral contraceptive use in future health studies.
Takeaway
This study found that using birth control pills can change a hormone called IGF-1 in women, and this change can last even after they stop using the pills.
Methodology
The study used adjusted linear regression analysis to examine the relationship between oral contraceptive use and IGF-1 levels in premenopausal women.
Potential Biases
There may be biases due to self-reported data on contraceptive use and missing information on confounding factors.
Limitations
The study lacked detailed information on the formulation of oral contraceptives used and some potential confounders.
Participant Demographics
Participants were premenopausal women aged 18 to 21 and 31 to 40, with a majority being East Asian or Caucasian.
Statistical Information
Confidence Interval
95% CI: -88.7, -25.8
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website